New Drug Against Breast Cancer Risk

Which is the active ingredient of the drug anastrozole, women at high risk of developing breast cancer can save your life emerged.

With a family history of breast cancer cases , menopausal women with a genetic predisposition research framework used in the drug containing anastrozole for 5 years . Following the study, 53 percent the risk of breast cancer were found to decrease .

The National Health System ( NHS ) does not yet , a drug approved for use of less side effects than other drugs that were also determined.

The study found that the active ingredient of drug use , especially the risk of other cancers , including skin and intestines also revealed that 42 per cent decrease .

Many breast cancer type of the hormone estrogen plays a role indicating that the scientists, the active ingredient anastrozole of the drug which , unlike the others , of the aromatase enzyme that produce the hormone by blocking the body's hormone levels decrease was noticed .

Other drugs to stop estrogen from binding to breast cancer cells, explaining that scientists, not from the ovaries of estrogen in menopausal women aromatase enzyme secreted by breast and muscle recalled.

Tony Howell of the signatories to the study of the results , the treatment of women in high-risk groups , as well as the rescue of thousands of women 's lives and extension management could provide an alternative treatment for stressed that an important step .

Scientists of this drug are at risk for women to develop breast cancer risk reduction in option should be said that the NHS breast cancer risk with this drug for the system to include urged .

Bu Haber için yorum yapabilirsiniz 31.12.2013 17:26:43 204.236.235.245

Yorumlar()